1. Locally advanced breast cancer;Sikov;Curr Treat Options Oncol,2000
2. Final results of a phase II randomized, parallel study of doxorubicin/cyclophosphamide (AC) and doxorubicin/Taxol (paclitaxel) (AT) as neoadjuvant treatment of local-regional breast cancer;Pouillart;Proc Am Soc Clin Oncol,1999
3. Six cycles of FEC100 vs. 6 cycles of epirubicin-docetaxel (ED) as neoadjuvant chemotherapy in operable breast cancer patients: preliminary results of a randomized phase II trial of GIREC S01;Luporsi;Proc Am Soc Clin Oncol,2000
4. The effect on primary tumor response of adding sequential Taxotere to Adriamycin and cyclophosphamide: preliminary results from NSABP protocol B-27. NSABP, Pittsburgh, PA;NSABP;Breast Cancer Res Treat,2001
5. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel;Smith;J Clin Oncol,2002